Context: Terminally ill patients (TIP) frequently visit the emergency department (ED), but the prevalence of these visits is unclear. Objective: To determine the prevalence of TIP visiting the ED. Methods: Systematic review of observational studies published between 1998 and 2018 reporting adults TIP who used the hospital ED, searching in PubMed, CINAHL, SciELO, LILACS, and Cochrane. Three evaluators selected and extracted data (kappa concordance 0.63). The quality of the studies was evaluated with the Newcastle–Ottawa scale and global estimates were made, calculating combined prevalence (95% confidence interval [CI]) and heterogeneity of the studies (I2). Results: We identified 2429 publications, ultimately including 31 studies in 14 countries; 79% were from high-income countries, 21% from medium-income countries, and none from low-income countries. Most were from 2015. We found that 45% of patients with cancer visited the ED in the last month of life [95% CI 37–54%] and 75% in the last six months of life [95% CI 62–83%]; I2 = 100%. Overall, 17% of patients who visited the ED had a terminal illness [95% CI 12–23%]; I2 = 98%. Few studies reported terminal nononcologic illness, specific age groups or diseases, hospital admission rates, use of palliative care or nonresuscitation, or other criteria that could be used for grouping. Conclusions: Patients with terminal cancer frequently use the ED at the end of life, although use varies among patients and few studies have examined low-income countries or patients with nononcologic terminal illness. The global prevalence of TIP in the ED cannot be calculated from limited reports.
Bibliographical noteFunding Information:
Dr. Marvin Delgado is supported in part by the National Institute of Health grant R01CA200867 and has no other potential conflicts of interest.
Special thanks to the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for editorial assistance. Funding: This work was supported by the Universidad Nacional Mayor de San Marcos, Lima, Peru [grant A18011241, 2018]. Dr. Marvin Delgado is supported in part by the National Institute of Health grant R01CA200867 and has no other potential conflicts of interest. Jose Amado, Teodoro Oscanoa, Rolando Vasquez and Roberto Huari have no other potential conflicts of interest to disclose.
Funding: This work was supported by the Universidad Nacional Mayor de San Marcos , Lima, Peru [grant A18011241, 2018 ].
© 2020 American Academy of Hospice and Palliative Medicine
Copyright 2021 Elsevier B.V., All rights reserved.
- Terminal care
- chronic disease
- emergency department
- systematic review